Media Releases

The test identifies different virus variants and improves disease prognosis.

In pursuit of particularly stable quantum bits, researchers have closely examined the electron distribution in two semiconductors.

PSI scientists have shed light on the structure of an important component of the eye: CNG ion channels whose job is to relay optical signals to the brain.

Boosted with superconductivity: Semiconductor technology can get a new twist by exploiting quantum effects in superconductors.

Kantonsspital Baden and the Paul Scherrer Institute PSI have signed a cooperation agreement.

Combining two chemotherapeutic drugs inhibits tumour growth.

The key is to eliminate methane leaks.

25 November 1996: a world first for PSI’s Center for Proton Therapy in treating a cancer patient using the spot-scanning technique.

On 9 November 2021 a lung cancer patient was given proton therapy at the Paul Scherrer Institute PSI for the first time in Switzerland.

New study explores methods for using waste gas efficiently.

Using light to fundamentally change the properties of solids

PSI researchers identify potential active agent against several unicellular parasites – including the pathogens that cause malaria and toxoplasmosis.

PSI researchers have developed a new method to attach proteins to the surface of virus-like particles.

Better treatment for disseminated cancer.

Why the shell of a marine animal is soft in water but hard in air.

Together with international colleagues, PSI researchers have now been able to make correlated metals more readily usable for applications in superconductivity, data processing, and quantum computers.

PSI is establishing a new research division: Scientific Computing, Theory, and Data.

Catalysts used in industry change their material structure over the years. Using a new method, PSI researchers have now studied this on the nanoscale.

Using a combination of computer simulations and laboratory experiments, PSI researchers have identified new binding sites for active agents on the vital protein tubulin.

The SURE research project is up and running.